AKT1 and cancer: This DMC downregulation occurs by DMC acting on PI3K-AKT-snail pathways to enhance the sensitivity of NSCLC to cisplatin, thereby increasing cisplatin-induced cytotoxicity and inducing cancer cell death [125].